Gaize has built the first real-time cannabis impairment test. The product runs an automated eye test using a VR headset and evaluates the resulting data using machine learning.
Current Status
Gaize is launching the cannabis impairment testing product in January 2023. We recently completed the largest cannabis impairment clinical trial ever conducted and are utilizing the results of this study for final accuracy tuning. This is the first real-time cannabis impairment testing product and is therefore a massive opportunity both financial and in terms of societal good. We have a significant number of pre-orders for the product and interest from extremely large and prominent businesses and law enforcement departments.
Problem or Opportunity
There is no product currently available that can determine impairment from cannabis. Tests that measure THC in the body as a proxy for impairment are not based in science and are only capable of determining prior use, not active impairment. This has created dangerous roads and dangerous workplaces as a result of cannabis use.
Solution (product or service)
We have solved this problem by creating a automated eye test that runs in a VR headset. Using embedded eye tracking sensors, we capture high precision data throughout the testing process. This data is then evaluated by statistical and machine learning models to determine the impairment or sobriety of the test subject in real-time. The result is a rapid test with extremely high accuracy and clear scientific backing.
Business model
Gaize operates on a SAAS model. We charge $399/month/unit.
